Garland Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
International Flavors & Fragrances
IFF
|
+$34.6K |
| 2 |
Vanguard Morningstar Small-Cap Value ETF
VBR
|
+$326 |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Organon & Co
OGN
|
+$2.83M |
| 2 |
IBM
IBM
|
+$430K |
| 3 |
Intel
INTC
|
+$384K |
| 4 |
JPMorgan Chase
JPM
|
+$375K |
| 5 |
Prudential Financial
PRU
|
+$364K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.58% |
| 2 | Financials | 19.44% |
| 3 | Technology | 11.41% |
| 4 | Real Estate | 10.89% |
| 5 | Industrials | 9.94% |
Similar funds
Garland Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Garland Capital Management held 34 positions worth $142M, up 0.42% from $142M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Garland Capital Management withdrew a net $9.73M in Q4 2023, closing 1 position and reducing 28 holdings. Its most notable exit was Organon & Co, an estimated $2.83M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 28% a quarter earlier, followed by Financials and Technology.
Against the trend, Garland Capital Management added an estimated $34.6K to International Flavors & Fragrances.
- Garland Capital Management added most to International Flavors & Fragrances in Q4 2023, an estimated $34.6K increase.
- Garland Capital Management's biggest Q4 2023 reduction was IBM, cutting an estimated $430K.
- Garland Capital Management fully exited Organon & Co in Q4 2023, selling an estimated $2.83M.
- Garland Capital Management's ten largest holdings make up 43% of its $142M portfolio in Q4 2023.
- Garland Capital Management opened 0 new positions and closed 1 in Q4 2023.
- Garland Capital Management's portfolio value rose 0.42% quarter-over-quarter to $142M.
Based on Garland Capital Management's 13F filing for Q4 2023, filed 29 Jan 2024.